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Nitric oxide (NO) has been proposed as an inhibitory neurotransmitter in guinea pig trachea. Studies were undertaken to examine the relaxant actions of NO and its possible role as a transmitter of nonadrenergic noncholinergic inhibitory (NANCI) nerves and as a modulator of contractile responses in guinea pig trachea.
Isometric responses were measured in paired segments of trachea and aorta mounted in organ baths filled with Krebs-Henseleit solution containing indomethacin, maintained at 37°C and gassed with 5% CO2 in 02. All relaxant responses were determined in precontracted tissues. The NANCI responses were evoked by electrical field stimulation (EFS) in tracheal segments treated with guanethidine, propranolol, and atropine. Effects of endogenously released NO were determined by treatment of tracheal segments with the NO synthase inhibitor, N-wnitro-L-arginine (NNA), prior to administration of contractile agonists.
Concentration 
METHODS
Cleavage of VIP labeled at tyrosine'0 with 1251 was determined by high performance liquid chromatography or acid precipitation. Antibodies were purified from plasma by affinity chromatography on immobilized protein G and VIP. The cDNA for a murine anti-VIP single chain Fv (scFv) and its L-chain subunit2 was cloned in a phagemid vector and the recombinant proteins were purified by metal-affinity chromatography.
RESULTS AND DISCUSSION
The IgG from >50% asthma patients (N 35) displayed significant hydrolysis of VIP, compared to <10% nonasthmatic control subjects (N 19). Four IgG samples each from asthmatics and nonasthmatics were analyzed for reaction kinetics. In each case, Michaelis-Menten kinetics was observed. The rates of peptide hydrolysis by antibodies from asthmatics were consistently greater than those from nonasthmatics. The kinetic efficiency of VIP-specific antibodies from an asthmatic (kcat/km 9.6X107 M-lsec-1) was within an order of magnitude of that for chymotrypsin. Taken 
